{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04116437",
            "orgStudyIdInfo": {
                "id": "BGB-3111-215"
            },
            "organization": {
                "fullName": "BeiGene",
                "class": "INDUSTRY"
            },
            "briefTitle": "Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment",
            "officialTitle": "A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients With Previously Treated B-Cell Lymphoma Intolerant of Prior Treatment With Ibrutinib and/or Acalabrutinib",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "zanubrutinib-bgb-in-participants-with-previously-treated-b-cell-lymphoma-intolerant-of-prior-bruton-tyrosine-kinase-inhibitor-btki-treatment"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": true,
                "nctId": "NCT04052854",
                "statusForNctId": "NO_LONGER_AVAILABLE"
            },
            "startDateStruct": {
                "date": "2019-10-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-10-01",
            "studyFirstSubmitQcDate": "2019-10-02",
            "studyFirstPostDateStruct": {
                "date": "2019-10-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "BeiGene",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The primary objective of this study is to evaluate the safety of zanubrutinib (also known as BGB-3111) in chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstr\u00f6m macroglobulinemia, mantle cell lymphoma, or marginal zone lymphoma patients who have become intolerant of prior ibrutinib and/or acalabrutinib treatment, by comparing intolerance to adverse event profile as assessed by the recurrence and the change in severity of adverse events."
        },
        "conditionsModule": {
            "conditions": [
                "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
                "Mantle Cell Lymphoma",
                "Marginal Zone Lymphoma",
                "Waldenstrom Macroglobulinemia"
            ],
            "keywords": [
                "BGB-3111",
                "Zanubrutinib",
                "Ibrutinib Intolerance",
                "BTK Inhibitor",
                "Acalabrutinib Intolerance"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 90,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Zanubrutinib",
                    "type": "EXPERIMENTAL",
                    "description": "Cohort 1: Chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL), Waldenstr\u00f6m macroglobulinemia (WM), mantle cell lymphoma (MCL), or marginal zone lymphoma (MZL) previously treated with ibrutinib\n\nCohort 2: Chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL), Waldenstr\u00f6m macroglobulinemia (WM), mantle cell lymphoma (MCL), or marginal zone lymphoma (MZL) previously treated with acalabrutinib alone/with ibrutinib",
                    "interventionNames": [
                        "Drug: Zanubrutinib"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Zanubrutinib",
                    "description": "Zanubrutinib (BGB-3111) will be orally administered at a dose of 160 mg twice daily or 320mg once daily until disease progression, unacceptable toxicity, treatment consent withdrawal, or study termination.",
                    "armGroupLabels": [
                        "Zanubrutinib"
                    ],
                    "otherNames": [
                        "BGB-3111",
                        "BRUKINSA"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Recurrence and change in severity of treatment-emergent Adverse Events (AEs) of interest.",
                    "timeFrame": "24 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Overall response as determined by investigator",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Progression free survival (PFS) as determined by investigator",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Patient reported outcomes as measured by EuroQol five dimension scale (EQ-5D)",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Patient reported outcomes as measured by European Organisation for Research and Treatment of Cancer (EORTC)",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Disease control rate as determined by investigator",
                    "timeFrame": "24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n1. Participants must meet protocol defined disease criteria requiring treatment for their respective disease prior to initiation of ibrutinib or acalabrutinib\n2. Ibrutinib and acalabrutinib intolerance is defined as an unacceptable toxicity where, in the opinion of the investigator, treatment should be discontinued in spite of optimal supportive care as a result of one of the following:\n\n   1. For ibrutinib and acalabrutinib intolerance events:\n\n      * 1 or more \u2265 Grade 2 nonhematologic toxicities for \\>7 days (with or without treatment)\n      * 1 or more \u2265 Grade 3 nonhematologic toxicity of any duration\n      * 1 or more Grade 3 neutropenia with infection or fever of any duration; or\n      * Grade 4 heme toxicity which persists to the point that the investigator chose to stop therapy due to toxicity NOT progression.\n   2. For acalabrutinib intolerance events only;\n\n      * 1 or more \u2265 Grade 1 nonhematologic toxicities of any duration with \\> 3 recurrent episodes; or\n      * 1 or more \u2265 Grade 1 nonhematologic toxicities for \\> 7 days (with or without treatment); or\n      * Inability to use acid-reducing agents or anticoagulants (eg, proton pump inhibitors, warfarin) due to concurrent acalabrutinib use\n3. Ibrutinib and/or acalabrutinib-related \u2265 Grade 2 toxicities must have resolved to \u2264 Grade 1 or baseline prior to initiating treatment with zanubrutinib. Grade 1 acalabrutinib-related toxicities must have resolved to Grade 0 or baseline prior to initiating treatment with zanubrutinib.\n4. Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2\n5. Absolute neutrophil count (ANC) \u2265 1000/mm\\^3 with or without growth factor support and platelet count \u2265 50,000/mm\\^3 (may be post-transfusion), on or prior to C1D1 of zanubrutinib\n\nKey Exclusion Criteria:\n\n1. Clinically significant cardiovascular disease including the following:\n\n   1. Myocardial infarction within 6 months before the Screening\n   2. Unstable angina within 3 months before the Screening\n   3. New York Heart Association class III or IV congestive heart failure\n   4. History of sustained ventricular tachycardia, ventricular fibrillation, and/or Torsades de Pointes\n   5. QT interval corrected by Fridericia's formula \\> 480 milliseconds\n   6. History of Mobitz II second-degree or third-degree heart block without a permanent pacemaker in place\n2. History of central nervous system (CNS) hemorrhage\n3. Documented progressive disease (PD) during ibrutinib and/or acalabrutinib treatment.\n4. Have received any anticancer therapy (other than immunotherapy) for CLL/SLL, WM, MCL, and MZL \\< 7 days before any Screening assessments are performed or any immunotherapy treatment, taken alone or as part of a chemoimmunotherapy regimen, \\< 4 weeks before any Screening assessments are performed\n5. Requires ongoing need for corticosteroid treatment \\> 10 mg daily of prednisone or equivalent corticosteroid. Note: Systemic corticosteroids must be fully tapered off/discontinued \u2265 5 days before the first dose of study drug is administered.\n\nNOTE: Other protocol defined Inclusion/Exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "BeiGene",
                    "role": "CONTACT",
                    "phone": "1-877-828-5568",
                    "email": "clinicaltrials@beigene.com"
                }
            ],
            "locations": [
                {
                    "facility": "Arizona Oncology Associates, Pc Hope",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85711",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "Rocky Mountain Cancer Centers (Williams) Usor",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80012",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Christiana Care",
                    "status": "RECRUITING",
                    "city": "Newark",
                    "state": "Delaware",
                    "zip": "19713",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.68372,
                        "lon": -75.74966
                    }
                },
                {
                    "facility": "Scri Florida Cancer Specialists South",
                    "status": "RECRUITING",
                    "city": "Fort Myers",
                    "state": "Florida",
                    "zip": "33901",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.62168,
                        "lon": -81.84059
                    }
                },
                {
                    "facility": "Scri Florida Cancer Specialists North",
                    "status": "RECRUITING",
                    "city": "Saint Petersburg",
                    "state": "Florida",
                    "zip": "33705",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.77086,
                        "lon": -82.67927
                    }
                },
                {
                    "facility": "Healthcare Research Network Iii, Llc",
                    "status": "RECRUITING",
                    "city": "Tinley Park",
                    "state": "Illinois",
                    "zip": "60487",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.57337,
                        "lon": -87.78449
                    }
                },
                {
                    "facility": "Minnesota Oncology Burnsville Clinic",
                    "status": "RECRUITING",
                    "city": "Burnsville",
                    "state": "Minnesota",
                    "zip": "55337",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 44.76774,
                        "lon": -93.27772
                    }
                },
                {
                    "facility": "Comprehensive Cancer Centers of Nevada",
                    "status": "RECRUITING",
                    "city": "Las Vegas",
                    "state": "Nevada",
                    "zip": "89169",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.17497,
                        "lon": -115.13722
                    }
                },
                {
                    "facility": "Summit Medical Group",
                    "status": "RECRUITING",
                    "city": "Florham Park",
                    "state": "New Jersey",
                    "zip": "07932",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.78788,
                        "lon": -74.38821
                    }
                },
                {
                    "facility": "Morristown Medical Center",
                    "status": "RECRUITING",
                    "city": "Morristown",
                    "state": "New Jersey",
                    "zip": "07960",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.79677,
                        "lon": -74.48154
                    }
                },
                {
                    "facility": "Clinical Research Alliance, Inc",
                    "status": "RECRUITING",
                    "city": "Westbury",
                    "state": "New York",
                    "zip": "11590",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.75566,
                        "lon": -73.58763
                    }
                },
                {
                    "facility": "Oncology Associates of Oregon Willamette Valley Cancer Center",
                    "status": "RECRUITING",
                    "city": "Eugene",
                    "state": "Oregon",
                    "zip": "97401",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 44.05207,
                        "lon": -123.08675
                    }
                },
                {
                    "facility": "St Lukes University Health Network",
                    "status": "RECRUITING",
                    "city": "Bethlehem",
                    "state": "Pennsylvania",
                    "zip": "18015",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.62593,
                        "lon": -75.37046
                    }
                },
                {
                    "facility": "Abington Hematology Oncology Associates",
                    "status": "RECRUITING",
                    "city": "Horsham",
                    "state": "Pennsylvania",
                    "zip": "19044",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.17844,
                        "lon": -75.12851
                    }
                },
                {
                    "facility": "Tennessee Oncology, Pllc Nashville",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Texas Oncology Amarillo",
                    "status": "RECRUITING",
                    "city": "Amarillo",
                    "state": "Texas",
                    "zip": "79106",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.222,
                        "lon": -101.8313
                    }
                },
                {
                    "facility": "Baylor Research Institute",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75246",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Texas Oncology McAllen South Second Street",
                    "status": "RECRUITING",
                    "city": "McAllen",
                    "state": "Texas",
                    "zip": "78503",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.20341,
                        "lon": -98.23001
                    }
                },
                {
                    "facility": "Texas Oncology Tyler Longview",
                    "status": "RECRUITING",
                    "city": "Tyler",
                    "state": "Texas",
                    "zip": "75702",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.35126,
                        "lon": -95.30106
                    }
                },
                {
                    "facility": "Us Oncology Virginia Cancer Specialists, Pc",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Virginia Oncology Associates Hampton",
                    "status": "RECRUITING",
                    "city": "Virginia Beach",
                    "state": "Virginia",
                    "zip": "23456",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.85293,
                        "lon": -75.97799
                    }
                },
                {
                    "facility": "Fred Hutchinson Cancer Research Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "Medical Oncology Associates",
                    "status": "RECRUITING",
                    "city": "Spokane",
                    "state": "Washington",
                    "zip": "99208",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.65966,
                        "lon": -117.42908
                    }
                },
                {
                    "facility": "Ssm Health Cancer Care Dean Medical Center",
                    "status": "RECRUITING",
                    "city": "Madison",
                    "state": "Wisconsin",
                    "zip": "53717",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.07305,
                        "lon": -89.40123
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "36400069",
                    "type": "DERIVED",
                    "citation": "Shadman M, Flinn IW, Levy MY, Porter RF, Burke JM, Zafar SF, Misleh J, Kingsley EC, Yimer HA, Freeman B, Rao SS, Chaudhry A, Tumula PK, Gandhi MD, Manda S, Chen DY, By K, Xu L, Liu Y, Crescenzo R, Idoine A, Zhang X, Cohen A, Huang J, Sharman JP. Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study. Lancet Haematol. 2023 Jan;10(1):e35-e45. doi: 10.1016/S2352-3026(22)00320-9. Epub 2022 Nov 16."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000015451",
                    "term": "Leukemia, Lymphocytic, Chronic, B-Cell"
                },
                {
                    "id": "D000020522",
                    "term": "Lymphoma, Mantle-Cell"
                },
                {
                    "id": "D000008258",
                    "term": "Waldenstrom Macroglobulinemia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000008228",
                    "term": "Lymphoma, Non-Hodgkin"
                },
                {
                    "id": "D000007945",
                    "term": "Leukemia, Lymphoid"
                },
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000015448",
                    "term": "Leukemia, B-Cell"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000054219",
                    "term": "Neoplasms, Plasma Cell"
                },
                {
                    "id": "D000020141",
                    "term": "Hemostatic Disorders"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000010265",
                    "term": "Paraproteinemias"
                },
                {
                    "id": "D000001796",
                    "term": "Blood Protein Disorders"
                },
                {
                    "id": "D000006474",
                    "term": "Hemorrhagic Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18116",
                    "name": "Leukemia, Lymphocytic, Chronic, B-Cell",
                    "asFound": "Small lymphocytic lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18828",
                    "name": "Lymphoma, B-Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M10951",
                    "name": "Leukemia, Lymphoid",
                    "relevance": "LOW"
                },
                {
                    "id": "M22307",
                    "name": "Lymphoma, Mantle-Cell",
                    "asFound": "Mantle Cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20554",
                    "name": "Lymphoma, B-Cell, Marginal Zone",
                    "relevance": "LOW"
                },
                {
                    "id": "M11251",
                    "name": "Waldenstrom Macroglobulinemia",
                    "asFound": "Waldenstrom Macroglobulinemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11222",
                    "name": "Lymphoma, Non-Hodgkin",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18115",
                    "name": "Leukemia, B-Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M27588",
                    "name": "Neoplasms, Plasma Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M21977",
                    "name": "Hemostatic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5059",
                    "name": "Blood Coagulation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13178",
                    "name": "Paraproteinemias",
                    "relevance": "LOW"
                },
                {
                    "id": "M5077",
                    "name": "Blood Protein Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9560",
                    "name": "Hemorrhagic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1308",
                    "name": "Chronic Lymphocytic Leukemia",
                    "asFound": "Chronic Lymphocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T640",
                    "name": "B-cell Lymphoma",
                    "asFound": "B-cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T3601",
                    "name": "Mantle Cell Lymphoma",
                    "asFound": "Mantle Cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3612",
                    "name": "Marginal Zone Lymphoma",
                    "asFound": "Marginal zone lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5887",
                    "name": "Waldenstrom Macroglobulinemia",
                    "asFound": "Waldenstrom Macroglobulinemia",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000629551",
                    "term": "Zanubrutinib"
                }
            ],
            "ancestors": [
                {
                    "id": "D000092004",
                    "term": "Tyrosine Kinase Inhibitors"
                },
                {
                    "id": "D000047428",
                    "term": "Protein Kinase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M42199",
                    "name": "Zanubrutinib",
                    "asFound": "Flavor",
                    "relevance": "HIGH"
                },
                {
                    "id": "M42185",
                    "name": "Acalabrutinib",
                    "relevance": "LOW"
                },
                {
                    "id": "M42179",
                    "name": "Ibrutinib",
                    "relevance": "LOW"
                },
                {
                    "id": "M2889",
                    "name": "Tyrosine Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M25820",
                    "name": "Protein Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T22",
                    "name": "Tyrosine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}